Kahveci, A. M., & Tahan, V. (2016). Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies. Turkish Journal of Gastroenterology, 27(1), 89–90. https://doi.org/10.5152/tjg.2015.150012